BIM
AERI

BlackRock Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

BlackRock Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.15M Buy
109,734
+16,244
+17% +$614K ﹤0.01% 1718
2016
Q3 		$3.53M Sell
93,490
-209
-0.2% -$4.61K ﹤0.01% 1734
2016
Q2 		$1.65M Buy
93,699
+19,551
+26% +$316K ﹤0.01% 2264
2016
Q1 		$902K Buy
74,148
+930
+1% +$14.7K ﹤0.01% 2556
2015
Q4 		$1.78M Sell
73,218
-47
-0.1% -$1.1K ﹤0.01% 2164
2015
Q3 		$1.3M Sell
73,265
-586
-0.8% -$10.6K ﹤0.01% 2404
2015
Q2 		$1.3M Buy
73,851
+43,450
+143% +$797K ﹤0.01% 2576
2015
Q1 		$953K Buy
30,401
+436
+1% +$12.6K ﹤0.01% 2550
2014
Q4 		$875K Sell
29,965
-611
-2% -$15.5K ﹤0.01% 2631
2014
Q3 		$633K Buy
30,576
+399
+1% +$7.87K ﹤0.01% 2833
2014
Q2 		$747K Buy
30,177
+7,644
+34% +$132K ﹤0.01% 2815
2014
Q1 		$477K Buy
22,533
+2,806
+14% +$56.7K ﹤0.01% 2976
2013
Q4 		$354K Buy
+19,727
New +$257K ﹤0.01% 3107

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Investment Management's AERI Position: Q4 2016 in Review

BlackRock Investment Management increased its Aerie Pharmaceuticals (AERI) stake by 17% in Q4 2016, buying an estimated $614K and bringing the position to 109,734 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

BlackRock Investment Management first reported a position in AERI in Q4 2013 and has held it in 13 quarters since. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • BlackRock Investment Management held 109,734 shares of Aerie Pharmaceuticals worth $4.15M as of Q4 2016.
  • BlackRock Investment Management bought 16,244 Aerie Pharmaceuticals shares in Q4 2016, an estimated $614K.
  • Aerie Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1718 holding.
  • BlackRock Investment Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and has held it in 13 quarters since.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.